Understanding the Shortcomings of Cystoscopy in Muscle Invasive Bladder Cancer
PHILADELPHIA (May 19, 2018) – Researchers at Fox Chase Cancer Center are seeking to solve a diagnostic dilemma inherent in current treatment recommendations for bladder cancer. This trial marks the first time the true negative predictive value of a normal cystoscopic evaluation is being identified, allowing researchers to establish how often bladder cancer hides under the mucosa and evades endoscopic diagnosis.